Mega deal: La Jolla startup Synthorx sells for $2.5 billion to Sanofi – The San Diego Union-Tribune

  1. Mega deal: La Jolla startup Synthorx sells for $2.5 billion to Sanofi  The San Diego Union-Tribune
  2. Sanofi, Maker of World’s Top-Selling Insulin, to Exit Diabetes Research  The Wall Street Journal
  3. Sanofi to Buy Synthorx for $2.5 Billion  Yahoo Finance
  4. Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value  Fortune
  5. Sanofi to acquire Synthorx for $2.5 billion  MarketWatch
  6. View full coverage on Google News